Therefore, while we provide promising findings from the manipulation of ADK isoforms in cellular behaviors of cancer cells, it is still premature to draw any firm conclusions regarding ADK isoforms as a specific biomarker in breast cancer. This evidence concerns the gene ADK and breast carcinoma.